Trial Transparency Campaigners Challenge Medical Journals Over 'Outcome Switching'
This article was originally published in SRA
Executive Summary
Trial transparency efforts are taking another step forward with two new ventures aimed at maximizing the reliability of clinical trial data in studies published in international medical journals and making it easier for researchers to access and manipulate information on the drugs database of the US Food and Drug Administration.